Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CFO Sells $13,373.40 in Stock

NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak sold 1,860 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total transaction of $13,373.40. Following the transaction, the chief financial officer now directly owns 22,227 shares in the company, valued at approximately $159,812.13. This trade represents a 7.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Jay Matushak also recently made the following trade(s):

• On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total transaction of $5,575.90.
• On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10.

NeueHealth Stock Performance

NYSE NEUE opened at $6.75 on Friday. The firm’s 50 day moving average price is $7.30 and its 200-day moving average price is $6.00. NeueHealth, Inc. has a 52-week low of $3.79 and a 52-week high of $7.66. The company has a market cap of $55.96 million, a PE ratio of -0.13 and a beta of 0.56.

Hedge Funds Weigh In On NeueHealth

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Partners Group Holding AG bought a new position in shares of NeueHealth during the third quarter valued at approximately $463,000. Northern Trust Corp boosted its stake in shares of NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in shares of NeueHealth during the fourth quarter valued at approximately $76,000. 63.88% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Royal Bank of Canada reduced their target price on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.